# A Study of the Safety and Efficacy of Long-Term Nebivolol Use in Hypertensive Patients

> **NCT00200499** · PHASE3 · COMPLETED · sponsor: **Mylan Bertek Pharmaceuticals** · enrollment: 845 (—)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Nebivolol

## Key facts

- **NCT ID:** NCT00200499
- **Lead sponsor:** Mylan Bertek Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** —
- **Final completion:** 2003-09
- **Target enrollment:** 845 (—)
- **Last updated:** 2005-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00200499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00200499, "A Study of the Safety and Efficacy of Long-Term Nebivolol Use in Hypertensive Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00200499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*